Clinical Trial Update: Effect of Sitagliptin on Incretin Effect in Patients With Type 2 Diabetes Mellitus [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the effect of sitagliptin on the incretin effect in patients with Type 2 Diabetes Mellitus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Sitagliptin (sitagliptin)

Snippet

Sponsor: Ludwig-Maximilians - University of Munich | Conditions: Type 2 Diabetes Mellitus | Phase 1 | Status: COMPLETED